Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta(Brigham and Women's Hospital), Sushrut S. Waikar(Boston University), Peter A. McCullough(Providence Hospital), Anand Srivastava(Northwestern University), Matthew W. Semler(Vanderbilt University Medical Center), Samaya J. Anumudu, Simon Correa(Brigham and Women's Hospital), David E. Leaf(Brigham and Women's Hospital), Adam Green(Morgan Adams Foundation), Jared Radbel(Rutgers, The State University of New Jersey), Andrew J. Admon(University of Michigan), Samuel Short(University of Vermont), Chirag R. Parikh(Johns Hopkins University), Amanda K. Leonberg‐Yoo(University of Pennsylvania), Hayley B. Gershengorn(University of Miami), Mary C. Mallappallil(Kings County Hospital Center), Kathleen F. Kopecky, Lili Chan(Icahn School of Medicine at Mount Sinai), Megan L. Krajewski, Carl P. Walther, Samantha K. Brenner(Hackensack University Medical Center), Justin Arunthamakun(Baylor University Medical Center), Michal L. Melamed(Albert Einstein College of Medicine), Juan Carlos Q. Velez(Ochsner Health System), Jochen Reiser(University of Miami), David J. Douin, Kapil K. Pokharel(Brigham and Women's Hospital), Anthony J. Faugno(Tufts Medical Center), Thuy-Duyen Nguyen, John P. Donnelly(University of Michigan), Kusum S. Mathews(Mount Sinai Health System), Miguel A. Hernán(Harvard University Press), Salim S. Hayek(Emory University), Gregory P. Milligan, Allon N. Friedman(Yamaha (Japan)), Edward J. Schenck(Cornell University), David M. Charytan(Royal North Shore Hospital), Ambarish M. Athavale(Cook County Health and Hospitals System), Jingjing Zhang(Thomas Jefferson University Hospital), Wei Wang(University of Illinois Urbana-Champaign), Juan D. Valencia, Yan Zhou(Nanyang Technological University), Anip Bansal(University of Colorado Anschutz Medical Campus), Diana G. Finkel(Rutgers, The State University of New Jersey), Shahzad Shaefi(Columbia University), Ameeka Pannu, Roberta E. Redfern(ProMedica Toledo Hospital)
Cited by 555
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k